Health News Releases

  • Today May 20
September 18, 2016 18:00
New LCP Monofilament Allows for MRI Guided Vascular Intervention
Magnetic resonance imaging (MRI) uses a strong magnetic field to image the body and is known as the gold standard in diagnostic imaging. This non-invasive imaging technique can be used to diagnose sev
September 13, 2016 18:30
Macrogen Launches ‘Easybox’, a Premium Temperature-Controlled Package
The precision medicine biotechnology enterprise Macrogen (CEO Hyeon-yong Jeong, www.macrogen.com) (KOSDAQ:038290) announced today its new premium temperature-controlled packaging named ‘EasyBox’ for c
September 13, 2016 11:40
Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL)
RFL is the largest grassroots fundraiser in the world and currently brings together cancer communities in more than 26 countries. Through this expansion, RFL expects to recruit and train new partners
September 13, 2016 11:25
Samsung Bioepis' SB4 (BRENZYS™) Becomes First Etanercept Biosimilar to Receive Regulatory Approval in Canada
Samsung Bioepis Co., Ltd. today announced that BRENZYS™ - a biosimilar referencing Enbrel® (etanercept), also known as SB4 - received regulatory approval in Canada for the treatment of rheumatoid arth
September 12, 2016 13:50
Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
Boehringer Ingelheim today announced that the European Commission (EC) and U.S. Food and Drug Administration (FDA) have granted Orphan Drug Designation to nintedanib for the treatment of systemic scle
September 09, 2016 15:45
Patient Safety Movement Foundation & Global Sepsis Alliance Join Forces to Reduce Preventable Deaths from Sepsis
The Patient Safety Movement Foundation is happy to announce its sponsorship and participation in the 1st World Sepsis Congress on September 8-9, 2016, convened by the Global Sepsis Alliance. Featured
September 08, 2016 15:50
New analysis showed dose adjustment of Giotrif® (afatinib) improved tolerability without an apparent impact on efficacy in patients with EGFR mutation-positive non-small cell lung cancer
Results from a new post-hoc analysis of two large Phase III trials (LUX-Lung 3 and LUX-Lung 6) assessing the impact of dose adjustments for Giotrif® (afatinib*) in patients with advanced non-small cel
September 08, 2016 14:45
GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance
W. L. Gore & Associates, Inc. (Gore) is celebrating the 20th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft for the treatment of complex periphera
September 08, 2016 11:00
New long-term data demonstrates continued safety and beneficial effect of OFEV® (nintedanib) for patients with IPF
Boehringer Ingelheim presented eight IPF-related abstracts at the European Respiratory Society (ERS) International Congress 2016, including new interim data from the INPULSIS®-ON extension trial asses
September 08, 2016 10:25
Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study (TIDES), a Phase 3
September 07, 2016 11:30
Tiotropium Respimat® improved lung function in children with asthma aged 6-17 and is well-tolerated compared to placebo in children aged 1-17[1-5]
Boehringer Ingelheim announced today new study results from the Phase III CanoTinA-asthma® trial that showed adding tiotropium Respimat® to maintenance asthma therapy significantly improved lung funct
September 06, 2016 10:15
New Data: Spiolto® Respimat® significantly improves exercise capacity in people with COPD
Boehringer Ingelheim today announced the first results from the Phase III PHYSACTO® trial that shows Spiolto® (tiotropium+olodaterol) Respimat®, combined with exercise training, helps people with COPD
September 06, 2016 09:55
Simple blood test combined with exacerbation history may help to identify when to add ICS to COPD treatment
Boehringer Ingelheim today announced a new post-hoc subanalysis of the WISDOM study that suggests only 4 out of 100 people with chronic obstructive pulmonary disease (COPD), who have a history of freq
September 02, 2016 13:55
ReSound® Returns to the World’s Largest Consumer Electronics Show in Berlin to Showcase the Most Advanced Hearing Solutions
ReSound returns this week to IFA, the world’s largest international consumer electronics show, to feature its award winning Smart Hearing aids and to help lead the current discussion on how to support
September 02, 2016 10:10
Takeda to develop Zika Vaccine with up to $312 million in funding from US Government
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that BARDA, the Biomedical Advanced Research and Development Authority, has selected Takeda’s Vaccine Business Unit to dev
September 01, 2016 14:05
Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind in Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that its global non-interventional, observational multiple myeloma study is now enrolling patients. Titled INSIGHT-MM, the study aims
August 31, 2016 13:35
GORE® DrySeal Flex Introducer Sheath Advances Care through Access
W. L. Gore & Associates, Inc. (Gore) today announced the commercial availability of the GORE® DrySeal Flex Introducer Sheath, after recently gaining clearance for use by regulatory bodies in the U.S.,
August 30, 2016 19:15
ESC Congress 2016 Late Breaking Science Registry
First outcome results from the GLORIA™-AF Registry show that treatment with dabigatran etexilate was associated with low incidences of stroke, major bleeding and life-threatening bleeding. The results
August 30, 2016 19:10
Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists (WFSA)
Masimo (NASDAQ: MASI) announced Sunday at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesth
August 30, 2016 14:00
Masimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb®) Monitoring for Areas Affected by the Zika Virus
Masimo (NASDAQ: MASI) announced today that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the
August 30, 2016 13:40
IMS Health and Quintiles Announce Key Officers for Merged Company
IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) today announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to th
August 29, 2016 17:45
Ferring Pharmaceuticals Acquires Exclusive Licensing Rights to Condoliase from Seikagaku Corporation
Ferring Pharmaceuticals announced today that it has signed an agreement with Seikagaku Corporation granting Ferring the exclusive worldwide rights (excluding Japan) to SI-6603 (condoliase), a chemonuc
August 29, 2016 11:20
Takeda Announces Bold, New Access to Medicines Strategy
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and potentially life-savin
August 19, 2016 14:00
Masimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate
Masimo (NASDAQ: MASI) announced today the CE Marking of RAS-45, a single-use adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™) of respiration rate (RRa®). Cont
August 17, 2016 16:00
Piramal Enterprises Enters into an Agreement to Acquire Ash Stevens Inc., a US based CDMO for High Potency APIs (HPAPIs)
Piramal Enterprises Limited (PEL, NSE: PEL, BSE: 500302) announced today that its wholly owned subsidiary in the US has entered into an agreement to acquire 100% stake in Ash Stevens Inc., a US based
25 per page50 per page75 per page100 per page